The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2008

Filed:

Mar. 21, 2002
Applicants:

Lisa Selsam Beavers, Franklin, IN (US);

Robert Alan Gadski, Indianapolis, IN (US);

Philip Arthur Hipskind, New Palestine, IN (US);

Craig William Lindsley, Schwenksville, PA (US);

Karen Lynn Lobb, Indianapolis, IN (US);

James Arthur Nixon, Indianapolis, IN (US);

Richard Todd Pickard, Noblesville, IN (US);

John Mehnert Schaus, Zionsville, IN (US);

Takako Takakuwa, Indianapolis, IN (US);

Brian Morgan Watson, Carmel, IN (US);

Inventors:

Lisa Selsam Beavers, Franklin, IN (US);

Robert Alan Gadski, Indianapolis, IN (US);

Philip Arthur Hipskind, New Palestine, IN (US);

Craig William Lindsley, Schwenksville, PA (US);

Karen Lynn Lobb, Indianapolis, IN (US);

James Arthur Nixon, Indianapolis, IN (US);

Richard Todd Pickard, Noblesville, IN (US);

John Mehnert Schaus, Zionsville, IN (US);

Takako Takakuwa, Indianapolis, IN (US);

Brian Morgan Watson, Carmel, IN (US);

Assignee:

Eli Lilly and Company, Indianapolis, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 217/22 (2006.01); A61K 31/47 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention discloses novel substituted aryl alkylamine compounds of Formula (I) or pharmaceutically acceptable salts thereof which have selective histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such cyclic amines as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases


Find Patent Forward Citations

Loading…